Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ildikó Krencz

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pathology Oncology Research : POR|February 19, 2026
Sample adequacy in bronchoscopic ROSE: comparison between laboratory specialist and pathologistGergő Szűcs, Judit Pápay, Eszter Regős, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 5, 2022
A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1Henriette Farkas, Csilla Máj, István Kenessey, et al.
Histopathology|October 31, 2025
GPNMB immunohistochemistry is a useful ancillary tool for the diagnosis of pulmonary lymphangioleiomyomatosisFatime Szalai, Judit Pápay, Katalin Dezső, et al.
Cancers|February 10, 2024
Rictor-A Mediator of Progression and Metastasis in Lung CancerFatime Szalai, Dániel Sztankovics, Ildikó Krencz, et al.
Human Pathology|December 28, 2016
Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinomaIldikó Krencz, Anna Sebestyén, Katalin Fábián, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2024
Comparison of molecular subtype composition between independent sets of primary and brain metastatic small cell lung carcinoma and matched samplesDániel Sztankovics, Fatime Szalai, Dorottya Moldvai, et al.
Pathology Oncology Research : POR|February 27, 2023
3D bioprinting and the revolution in experimental cancer model systems-A review of developing new models and experiences with <i>in vitro</i> 3D bioprinted breast cancer tissue-mimetic structuresDániel Sztankovics, Dorottya Moldvai, Gábor Petővári, et al.
Pathology Oncology Research : POR|May 6, 2024
<i>RICTOR</i> amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinomaIldikó Krencz, Dániel Sztankovics, Anna Sebestyén, et al.
European Journal of Cell Biology|November 21, 2024
Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progressionDániel Sztankovics, Fatime Szalai, Dorottya Moldvai, et al.
Magyar Onkologia|September 28, 2023
[Effects of 3D tissue structure on drug sensitivity - 3D bioprinted tissue mimetic structures in cancer research]Dorottya Moldvai, Dániel Sztankovics, Titanilla Dankó, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pathology Oncology Research : POR|February 19, 2026
Sample adequacy in bronchoscopic ROSE: comparison between laboratory specialist and pathologistGergő Szűcs, Judit Pápay, Eszter Regős, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 5, 2022
A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1Henriette Farkas, Csilla Máj, István Kenessey, et al.
Histopathology|October 31, 2025
GPNMB immunohistochemistry is a useful ancillary tool for the diagnosis of pulmonary lymphangioleiomyomatosisFatime Szalai, Judit Pápay, Katalin Dezső, et al.
Cancers|February 10, 2024
Rictor-A Mediator of Progression and Metastasis in Lung CancerFatime Szalai, Dániel Sztankovics, Ildikó Krencz, et al.
Human Pathology|December 28, 2016
Expression of mTORC1/2-related proteins in primary and brain metastatic lung adenocarcinomaIldikó Krencz, Anna Sebestyén, Katalin Fábián, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2024
Comparison of molecular subtype composition between independent sets of primary and brain metastatic small cell lung carcinoma and matched samplesDániel Sztankovics, Fatime Szalai, Dorottya Moldvai, et al.
Pathology Oncology Research : POR|February 27, 2023
3D bioprinting and the revolution in experimental cancer model systems-A review of developing new models and experiences with <i>in vitro</i> 3D bioprinted breast cancer tissue-mimetic structuresDániel Sztankovics, Dorottya Moldvai, Gábor Petővári, et al.
Pathology Oncology Research : POR|May 6, 2024
<i>RICTOR</i> amplification is associated with Rictor membrane staining and does not correlate with PD-L1 expression in lung squamous cell carcinomaIldikó Krencz, Dániel Sztankovics, Anna Sebestyén, et al.
European Journal of Cell Biology|November 21, 2024
Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progressionDániel Sztankovics, Fatime Szalai, Dorottya Moldvai, et al.
Magyar Onkologia|September 28, 2023
[Effects of 3D tissue structure on drug sensitivity - 3D bioprinted tissue mimetic structures in cancer research]Dorottya Moldvai, Dániel Sztankovics, Titanilla Dankó, et al.
Pageof 3